Nemocnice České Budějovice

Recent papers from Nemocnice České Budějovice

1. Comparison of risankizumab and upadacitinib treatment persistence according to disease location in patients with Crohn’s disease: data from the CREdIT registryInflammatory Bowel Diseases · 2026
2. Late atrial migration of a transcatheter mitral valve despite prior valve-in-valve TAVIKardiologia Polska · 2026
3. Translating avelumab maintenance into clinical practice: nationwide outcomes in Czech patients with advanced or metastatic urothelial carcinomaFuture Oncology · 2026
4. Long-term treatment with soluble guanylyl cyclase stimulator BAY41–8543 abolishes malignant hypertension-related mortality and attenuates organ damage: studies in Ren-2 transgenic rats treated with L-NAMEJournal of Hypertension · 2026
5. Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosisBrain · 2026
6. Clinic-based severity and prevalence of contractures in stroke: a retrospective, cross-sectional observational study from the SPAstic REgistryDisability and Rehabilitation · 2026
7. Automated insulin delivery in war refugee children with type 1 diabetes: a 3-year follow-upFrontiers in Endocrinology · 2026
8. Gerstmann-Sträussler-Scheinker syndrome with unexpected concomitant GRN variant: case reportFrontiers in Neuroscience · 2026
9. Peri-implant soft tissue colonization after osteosynthesis in asymptomatic patients: a prospective studyEuropean Journal of Orthopaedic Surgery & Traumatology · 2026
10. Pulsed field ablation as first-line therapy for the treatment of atrial fibrillation: a FARADISE sub-analysisEP Europace · 2026
11. AI assistance reduces missed fractures on musculoskeletal radiographs: A multicentre multi-reader crossover studyEuropean Journal of Radiology Artificial Intelligence · 2026
12. Is Cladribine a Suitable Strategy after Natalizumab in MS? Real-world Outcomes (P4-20.007)Neurology · 2026
13. Five-by-Five: Nationwide Real-world Outcomes after ≥Five Years of Cladribine With an Age ≥50 Subanalysis (P2-20.006)Neurology · 2026
14. Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort studyJournal of Neurology Neurosurgery & Psychiatry · 2026
15. Abstract Number: Esoc2026a1923 Predicting Stroke Mimics Before Imaging: A Multicentre Prospective Model From Prehospital and Early in-Hospital DataEuropean Stroke Journal · 2026
16. Abstract Number: Esoc2026a2243 Predicting Stroke Mimics in Acute Stroke Pathways: Clinical and Early Imaging Predictors From an 18-Month Multicentre Prospective CohortEuropean Stroke Journal · 2026
17. P25 | Real-World Outcomes in Newly Diagnosed Multiple Myeloma: Evidence Supporting Bortezomib–lenalidomide–dexamethasone as a Preferred Regimen Without Anti-Cd38 AntibodiesHaematologica · 2026
18. P75 | Current Status of Registry of Monoclonal Gammopathies - The Czech Myeloma Group "Real World“ DatabaseHaematologica · 2026
19. Levodopa/Carbidopa Intestinal Gel ( LCIG ) Treatment in a Patient with Parkinson's Disease and Hemophilia AMovement Disorders Clinical Practice · 2026
20. Persistence of advanced therapies in patients with ulcerative colitis: real-world data from the nationwide CREdIT registryTherapeutic Advances in Gastroenterology · 2026